Global Renal Drugs Market Growth (Status and Outlook) 2020-2025
According to this study, over the next five years the Renal Drugs market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Renal Drugs business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Renal Drugs market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Renal Drugs, covering the supply chain analysis, impact assessment to the Renal Drugs market size growth rate in several scenarios, and the measures to be undertaken by Renal Drugs companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020 in Section 2.3; and forecast to 2025 in section 10.7.
Oral
Injections
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2025 in section 10.8.
Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Mylan
Roche Holding
Bausch Health Companies
Apotex
Endo International
Dava Pharmaceuticals
Cardinal Health
Fresenius
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Renal Drugs market size by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Renal Drugs market by identifying its various subsegments.
Focuses on the key global Renal Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Renal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Renal Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Renal Drugs Market Size 2015-2025
2.1.2 Renal Drugs Market Size CAGR by Region
2.2 Renal Drugs Segment by Type
2.2.1 Oral
2.2.2 Oral
2.3 Renal Drugs Market Size by Type
2.3.1 Global Renal Drugs Market Size Market Share by Type (2015-2020)
2.3.2 Global Renal Drugs Market Size Growth Rate by Type (2015-2020)
2.4 Renal Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacies
2.4.3 Drug Stores
2.4.4 Online Pharmacy
2.4.5 Others
2.5 Renal Drugs Market Size by Application
2.5.1 Global Renal Drugs Market Size Market Share by Application (2015-2020)
2.5.2 Global Renal Drugs Market Size Growth Rate by Application (2015-2020)
3 Global Renal Drugs by Players
3.1 Global Renal Drugs Market Size Market Share by Players
3.1.1 Global Renal Drugs Market Size by Players (2018-2020)
3.1.2 Global Renal Drugs Market Size Market Share by Players (2018-2020)
3.2 Global Renal Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Renal Drugs by Regions
4.1 Renal Drugs Market Size by Regions
4.2 Americas Renal Drugs Market Size Growth
4.3 APAC Renal Drugs Market Size Growth
4.4 Europe Renal Drugs Market Size Growth
4.5 Middle East & Africa Renal Drugs Market Size Growth
5 Americas
5.1 Americas Renal Drugs Market Size by Countries
5.2 Americas Renal Drugs Market Size by Type
5.3 Americas Renal Drugs Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Renal Drugs Market Size by Regions
6.2 APAC Renal Drugs Market Size by Type
6.3 APAC Renal Drugs Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Renal Drugs by Countries
7.2 Europe Renal Drugs Market Size by Type
7.3 Europe Renal Drugs Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Renal Drugs by Countries
8.2 Middle East & Africa Renal Drugs Market Size by Type
8.3 Middle East & Africa Renal Drugs Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Renal Drugs Market Forecast
10.1 Global Renal Drugs Market Size Forecast (2021-2025)
10.2 Global Renal Drugs Forecast by Regions
10.2.1 Global Renal Drugs Forecast by Regions (2021-2025)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Renal Drugs Forecast by Type
10.8 Global Renal Drugs Forecast by Application
11 Key Players Analysis
11.1 Mylan
11.1.1 Company Details
11.1.2 Renal Drugs Product Offered
11.1.3 Mylan Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.1.4 Main Business Overview
11.1.5 Mylan News
11.2 Roche Holding
11.2.1 Company Details
11.2.2 Renal Drugs Product Offered
11.2.3 Roche Holding Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.2.4 Main Business Overview
11.2.5 Roche Holding News
11.3 Bausch Health Companies
11.3.1 Company Details
11.3.2 Renal Drugs Product Offered
11.3.3 Bausch Health Companies Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.3.4 Main Business Overview
11.3.5 Bausch Health Companies News
11.4 Apotex
11.4.1 Company Details
11.4.2 Renal Drugs Product Offered
11.4.3 Apotex Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.4.4 Main Business Overview
11.4.5 Apotex News
11.5 Endo International
11.5.1 Company Details
11.5.2 Renal Drugs Product Offered
11.5.3 Endo International Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.5.4 Main Business Overview
11.5.5 Endo International News
11.6 Dava Pharmaceuticals
11.6.1 Company Details
11.6.2 Renal Drugs Product Offered
11.6.3 Dava Pharmaceuticals Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.6.4 Main Business Overview
11.6.5 Dava Pharmaceuticals News
11.7 Cardinal Health
11.7.1 Company Details
11.7.2 Renal Drugs Product Offered
11.7.3 Cardinal Health Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.7.4 Main Business Overview
11.7.5 Cardinal Health News
11.8 Fresenius
11.8.1 Company Details
11.8.2 Renal Drugs Product Offered
11.8.3 Fresenius Renal Drugs Revenue, Gross Margin and Market Share (2018-2020)
11.8.4 Main Business Overview
11.8.5 Fresenius News
12 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Renal Drugs Market Size CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral
Table 5. Major Players of Injections
Table 6. Renal Drugs Market Size by Type (2014-2019) ($ Millions)
Table 7. Global Renal Drugs Market Size Market Share by Type (2015-2020)
Table 8. Global Renal Drugs Market Size by Application (2015-2020) ($ Millions)
Table 9. Global Renal Drugs Market Size Market Share by Application (2015-2020)
Table 10. Global Renal Drugs Revenue by Players (2018-2020) ($ Millions)
Table 11. Global Renal Drugs Revenue Market Share by Players (2018-2020)
Table 12. Global Renal Drugs Key Players Head office and Products Offered
Table 13. Renal Drugs Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Renal Drugs Market Size by Regions 2015-2020 ($ Millions)
Table 17. Global Renal Drugs Market Size Market Share by Regions 2015-2020
Table 18. Americas Renal Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 19. Americas Renal Drugs Market Size Market Share by Countries (2015-2020)
Table 20. Americas Renal Drugs Market Size by Type (2015-2020) ($ Millions)
Table 21. Americas Renal Drugs Market Size Market Share by Type (2015-2020)
Table 22. Americas Renal Drugs Market Size by Application (2015-2020) ($ Millions)
Table 23. Americas Renal Drugs Market Size Market Share by Application (2015-2020)
Table 24. APAC Renal Drugs Market Size by Regions (2015-2020) ($ Millions)
Table 25. APAC Renal Drugs Market Size Market Share by Regions (2015-2020)
Table 26. APAC Renal Drugs Market Size by Type (2015-2020) ($ Millions)
Table 27. APAC Renal Drugs Market Size Market Share by Type (2015-2020)
Table 28. APAC Renal Drugs Market Size by Application (2015-2020) ($ Millions)
Table 29. APAC Renal Drugs Market Size Market Share by Application (2015-2020)
Table 30. Europe Renal Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 31. Europe Renal Drugs Market Size Market Share by Countries (2015-2020)
Table 32. Europe Renal Drugs Market Size by Type (2015-2020) ($ Millions)
Table 33. Europe Renal Drugs Market Size Market Share by Type (2015-2020)
Table 34. Europe Renal Drugs Market Size by Application (2015-2020) ($ Millions)
Table 35. Europe Renal Drugs Market Size Market Share by Application (2015-2020)
Table 36. Middle East & Africa Renal Drugs Market Size by Countries (2015-2020) ($ Millions)
Table 37. Middle East & Africa Renal Drugs Market Size Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Renal Drugs Market Size by Type (2015-2020) ($ Millions)
Table 39. Middle East & Africa Renal Drugs Market Size Market Share by Type (2015-2020)
Table 40. Middle East & Africa Renal Drugs Market Size by Application (2015-2020) ($ Millions)
Table 41. Middle East & Africa Renal Drugs Market Size Market Share by Application (2015-2020)
Table 42. Key and Potential Regions of Renal Drugs
Table 43. Key Application and Potential Industries of Renal Drugs
Table 44. Key Challenges of Renal Drugs
Table 45. Key Trends of Renal Drugs
Table 46. Global Renal Drugs Market Size Forecast by Regions (2021-2025) ($ Millions)
Table 47. Global Renal Drugs Market Size Market Share Forecast by Regions
Table 48. Global Renal Drugs Market Size Forecast by Type (2021-2025) ($ Millions)
Table 49. Global Renal Drugs Market Size Market Share Forecast by Type (2021-2025)
Table 50. Global Renal Drugs Market Size Forecast by Application (2021-2025) ($ Millions)
Table 51. Global Renal Drugs Market Size Market Share Forecast by Application (2021-2025)
Table 52. Mylan Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 53. Mylan Renal Drugs Product Offered
Table 54. Mylan Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 55. Mylan Main Business
Table 56. Mylan Latest Developments
Table 57. Roche Holding Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 58. Roche Holding Renal Drugs Product Offered
Table 59. Roche Holding Main Business
Table 60. Roche Holding Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 61. Roche Holding Latest Developments
Table 62. Bausch Health Companies Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 63. Bausch Health Companies Renal Drugs Product Offered
Table 64. Bausch Health Companies Main Business
Table 65. Bausch Health Companies Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 66. Bausch Health Companies Latest Developments
Table 67. Apotex Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 68. Apotex Renal Drugs Product Offered
Table 69. Apotex Main Business
Table 70. Apotex Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 71. Apotex Latest Developments
Table 72. Endo International Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 73. Endo International Renal Drugs Product Offered
Table 74. Endo International Main Business
Table 75. Endo International Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 76. Endo International Latest Developments
Table 77. Dava Pharmaceuticals Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 78. Dava Pharmaceuticals Renal Drugs Product Offered
Table 79. Dava Pharmaceuticals Main Business
Table 80. Dava Pharmaceuticals Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 81. Dava Pharmaceuticals Latest Developments
Table 82. Cardinal Health Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 83. Cardinal Health Renal Drugs Product Offered
Table 84. Cardinal Health Main Business
Table 85. Cardinal Health Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 86. Cardinal Health Latest Developments
Table 87. Fresenius Details, Company Total Revenue (in $ million), Head Office, Renal Drugs Major Market Areas and Its Competitors
Table 88. Fresenius Renal Drugs Product Offered
Table 89. Fresenius Main Business
Table 90. Fresenius Renal Drugs Revenue and Gross Margin (2018-2020E)
Table 91. Fresenius Latest Developments
List of Figures
Figure 1. Renal Drugs Report Years Considered
Figure 2. Market Research Methodology
Figure 3. Global Renal Drugs Market Size Growth Rate 2015-2025 ($ Millions)
Figure 4. Global Renal Drugs Market Size Market Share by Type (2015-2020)
Figure 5. Global Oral Market Size Growth Rate
Figure 6. Global Injections Market Size Growth Rate
Figure 7. Renal Drugs in Hospital Pharmacy
Figure 8. Global Renal Drugs Market: Hospital Pharmacy (2015-2020) ($ Millions)
Figure 9. Renal Drugs in Retail Pharmacies
Figure 10. Global Renal Drugs Market: Retail Pharmacies (2015-2020) ($ Millions)
Figure 11. Renal Drugs in Drug Stores
Figure 12. Global Renal Drugs Market: Drug Stores (2015-2020) ($ Millions)
Figure 13. Global Drug Stores YoY Growth ($ Millions)
Figure 14. Renal Drugs in Online Pharmacy
Figure 15. Global Renal Drugs Market: Online Pharmacy (2015-2020) ($ Millions)
Figure 16. Global Online Pharmacy YoY Growth ($ Millions)
Figure 17. Renal Drugs in Others
Figure 18. Global Renal Drugs Market: Others (2015-2020) ($ Millions)
Figure 19. Global Others YoY Growth ($ Millions)
Figure 20. Global Renal Drugs Market Size Market Share by Application in 2019
Figure 21. Global Renal Drugs Market Size Market Share by Regions 2015-2020
Figure 22. Americas Renal Drugs Market Size 2015-2020 ($ Millions)
Figure 23. APAC Renal Drugs Market Size 2015-2020 ($ Millions)
Figure 24. Europe Renal Drugs Market Size 2015-2020 ($ Millions)
Figure 25. Middle East & Africa Renal Drugs Market Size 2015-2020 ($ Millions)
Figure 26. Americas Renal Drugs Market Size Market Share by Countries in 2019
Figure 27. Americas Renal Drugs Market Size Market Share by Type in 2019
Figure 28. Americas Renal Drugs Market Size Market Share by Application in 2019
Figure 29. United States Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 30. Canada Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 31. Mexico Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 32. APAC Renal Drugs Market Size Market Share by Regions in 2019
Figure 33. APAC Renal Drugs Market Size Market Share by Type in 2019
Figure 34. APAC Renal Drugs Market Size Market Share by Application in 2019
Figure 35. China Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 36. Japan Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 37. Korea Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 38. Southeast Asia Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 39. India Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 40. Australia Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 41. Europe Renal Drugs Market Size Market Share by Countries in 2019
Figure 42. Europe Renal Drugs Market Size Market Share by Type in 2019
Figure 43. Europe Renal Drugs Market Size Market Share by Application in 2019
Figure 44. Germany Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 45. France Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 46. UK Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 47. Italy Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 48. Russia Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 49. Spain Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 50. Middle East & Africa Renal Drugs Market Size Market Share by Countries in 2019
Figure 51. Middle East & Africa Renal Drugs Market Size Market Share by Type in 2019
Figure 52. Middle East & Africa Renal Drugs Market Size Market Share by Application in 2019
Figure 53. Egypt Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 54. South Africa Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 55. Israel Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 56. Turkey Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 57. GCC Countries Renal Drugs Market Size Growth 2015-2020 ($ Millions)
Figure 58. Global Renal Drugs arket Size Forecast (2021-2025) ($ Millions)
Figure 59. Americas Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 60. APAC Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 61. Europe Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 62. Middle East & Africa Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 63. United States Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 64. Canada Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 65. Mexico Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 66. Brazil Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 67. China Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 68. Japan Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 69. Korea Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 70. Southeast Asia Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 71. India Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 72. Australia Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 73. Germany Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 74. France Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 75. UK Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 76. Italy Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 77. Russia Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 78. Spain Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 79. Egypt Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 80. South Africa Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 81. Israel Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 82. Turkey Renal Drugs Market Size 2021-2025 ($ Millions)
Figure 83. GCC Countries Renal Drugs Market Size 2021-2025 ($ Millions)
